Medical Therapy for Heart Failure With Reduced Ejection Fraction

Stephen J. Greene; Javed Butler; Nancy M. Albert; Adam D. DeVore; Puza P. Sharma; Carol I. Duffy; C. Larry Hill; Kevin McCague; Xiaojuan Mi; J. Herbert Patterson; John A. Spertus; Laine Thomas; Fredonia B. Williams; Adrian F. Hernandez; Gregg C. Fonarow

doi:10.1016/j.jacc.2018.04.070

Keywords

MedicineEjection fractionHeart failureInternal medicineACE inhibitorEnalaprilBeta blockerCardiologyAngiotensin receptorDosingBlood pressureAngiotensin-converting enzymeAngiotensin II

Affiliated Institutions

Related Publications

Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart Failure

Milton Packer , Robert M. Califf , Marvin A. Konstam +4 more

Background— Combined inhibition of the angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP) may produce greater benefits in heart failure than ACE inhibition alon...

2002 Circulation 623 citations

A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure

Jay N. Cohn , Gianni Tognoni

Valsartan significantly reduces the combined end point of mortality and morbidity and improves clinical signs and symptoms in patients with heart failure, when added to prescrib...

2001 New England Journal of Medicine 3079 citations

Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction

James B. Young , Mark E. Dunlap , Marc A. Pfeffer +15 more

Background— Patients with symptomatic chronic heart failure (CHF) and reduced left ventricular ejection fraction (LVEF) have a high risk of death and hospitalization for CHF det...

2004 Circulation 393 citations

Baseline characteristics and treatment of patients in Prospective comparison of <scp>ARNI</scp> with <scp>ACEI</scp> to Determine Impact on Global Mortality and morbidity in Heart Failure trial (<scp>PARADIGM‐HF</scp>)

John J.V. McMurray , Milton Packer , Akshay S. Desai +8 more

Aim To describe the baseline characteristics and treatment of the patients randomized in the PARADIGM‐HF (Prospective comparison of ARNi with ACEi to Determine Impact on Global ...

2014 European Journal of Heart Failure 167 citations

A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Lars Køber , Christian Torp‐Pedersen , Jan E. Carlsen +10 more

Long-term treatment with trandolapril in patients with reduced left ventricular function soon after myocardial infarction significantly reduced the risk of overall mortality, mo...

1995 New England Journal of Medicine 1765 citations

Publication Info

Year: 2018
Type: article
Volume: 72
Issue: 4
Pages: 351-366
Citations: 1151
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Medical Therapy for Heart Failure With Reduced Ejection Fraction

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1151

OpenAlex

Cite This

APA Style

                            
                                
                                    Stephen J. Greene, 
                                
                                    Javed Butler, 
                                
                                    Nancy M. Albert
                                
                                et al.
                            
                            (2018). 
                            Medical Therapy for Heart Failure With Reduced Ejection Fraction. 
                            Journal of the American College of Cardiology
                            , 72
                            (4)
                            , 351-366.
                            https://doi.org/10.1016/j.jacc.2018.04.070
                        

Identifiers

DOI: 10.1016/j.jacc.2018.04.070